NFKB1 and non-small cell lung carcinoma: miR-146a expression was found to be consistently lower in DDP-resistant (cisplatin) NSCLC samples and cell lines (A549, Calu-1), along with elevated levels of NF-kB activity and TNFα signaling adapter proteins like TRAF6, IRAK1.